Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Jun 27 2023

Full Issue

Viewpoints: FDA's Befuddling Grammar Is Hurting Pharma Research

Opinion writers discuss public health issues.

Stat: Drug Repurposing Or Repositioning? The Language Matters

For pharmaceutical companies, universities, and research organizations to cooperate efficiently, they need to agree on definitions. And right now, there are no clear FDA guidelines on the difference between “drug repositioning” and “drug repurposing.” As a consequence, researchers struggle to find willing partners, and opportunities for collaboration proceed more slowly than necessary, if they happen at all. (Annette Bakker, 6/27)

Alabama Political Reporter: The Bungling Of The Medical Marijuana Licenses Is Hurting Desperate Alabamians

On May 17, 2021, Gov. Kay Ivey signed a bill that would legalize medical marijuana in the state of Alabama. That’s more than two years ago, just so we’re clear. A little more than one week ago, the Alabama Cannabis Commission – the government entity created by the legislature to enforce regulations and issue licenses to companies that can deliver medical marijuana to the people of Alabama – had to put a stay on the first licenses the Commission ever approved. On Friday, a Montgomery County Circuit Court judge issued his own stay on those licenses, ensuring that the process will be tied up in litigation and paperwork for months to come. And somewhere in this state, there’s a sick kid or a pain-riddled grandma who could be aided by medical marijuana but who will instead suffer on. (Josh Moon, 6/26)

San Francisco Chronicle: I Coined The Word Cisgender. Here’s What Elon Musk Gets Wrong About It

Some in the LGBTQ community have asserted that the term cisgender is disrespectful because it doesn’t represent the complicated relationships with gender that many in the community experience. It is valid that many of us in the LGBTQ community operate outside the boundaries of expected gender identity and expression associated with sex assigned at birth and are not cisgender. Having a gender identity assigned to you is never appropriate, but using a term inappropriately, while hurtful, has nothing to do with the validity of the underlying construct. (Dana Defosse, 6/26)

The Washington Post: What The Fat-Shamers Don’t Get About Lizzo

For years, Lizzo has faced backlash from people made uncomfortable by her unabashed acceptance of herself — who would rather see her concealed in oversize cardigans and potato sacks. “What about her weight?” people say. “She’s promoting obesity!” No, she isn’t. There’s a difference between endorsing obesity and practicing self-love. (Danielle Pinnock, 6/26)

Los Angeles Times: Another Finding That COVID Didn't Come From A Lab 

That sound you may have detected rising from the ether of social media this weekend was the gnashing of teeth by COVID conspiracy-mongers, outraged by a U.S. government report debunking their most cherished claims. The long-awaited report released Friday by the Office of the Director of National Intelligence, or ODNI, put the lie to the theory that the Sars-CoV-2 virus, which causes COVID, leaked from a virology lab in Wuhan, China, where the disease was first detected in humans. The lab-leak conspiracists were certain that the report would validate their contentions, for which there has never been any valid scientific evidence. Instead it did just the opposite. (Michael Hiltzik, 6/26)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Tuesday, June 16
  • Monday, June 15
  • Friday, June 12
  • Thursday, June 11
  • Wednesday, June 10
  • Tuesday, June 9
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF